Astles Rachel, Liu Zihao, Gillespie Scott E, Lai Kristina W, Maillis Alexander, Morris Claudia R, Lane Peter A, Krishnamurti Lakshmanan, Bakshi Nitya
Emory University School of Medicine, Atlanta, GA, USA.
Rollins School of Public Health, Emory University, Atlanta, GA, USA.
Pain Rep. 2023 Aug 7;8(5):e1084. doi: 10.1097/PR9.0000000000001084. eCollection 2023 Sep.
INTRODUCTION/OBJECTIVE: Acute pain episodes are a major cause of health care utilization (HCU) in sickle cell disease (SCD), and adolescence is associated with increased pain frequency. We sought to determine whether there were differences in acute pain trajectories by sex and frequency of pain episodes among adolescents with SCD who presented to the emergency department (ED).
Retrospective review of electronic health records from a large, multicampus, pediatric SCD program.
Of the 113 adolescents included, the mean age was 16.6 (SD 0.9), 41.6% (n = 47) were female, 77.9% (n = 88) had HbSS or a similarly severe genotype, and 43.4% (n = 49) had ≥3 episodes of HCU for pain, which we defined as having history of high HCU for pain. Those with a history of high HCU for pain had higher mean pain intensity scores at presentation, were more likely to receive either intravenous or intranasal opioids, and were more likely to be hospitalized. In a model considering the 3-way interaction between sex, history of high HCU for pain, and follow-up time from the initial pain intensity score, adjusted for opioid per kilogram body weight, and prescription of hydroxyurea, adolescent female patients with high HCU for pain had the slowest decline in pain intensity during treatment for acute pain in the ED.
Sex and history of high HCU for pain are associated with acute pain trajectories in adolescents with SCD presenting to the ED. These novel findings should be confirmed in future prospective studies.
引言/目的:急性疼痛发作是镰状细胞病(SCD)患者医疗保健利用(HCU)的主要原因,而青春期与疼痛发作频率增加有关。我们试图确定在前往急诊科(ED)就诊的SCD青少年中,急性疼痛轨迹在性别和疼痛发作频率方面是否存在差异。
对一个大型多校区儿科SCD项目的电子健康记录进行回顾性分析。
纳入的113名青少年中,平均年龄为16.6岁(标准差0.9),41.6%(n = 47)为女性,77.9%(n = 88)患有HbSS或类似严重基因型,43.4%(n = 49)有≥3次因疼痛导致的HCU发作,我们将其定义为有高HCU疼痛史。有高HCU疼痛史的患者在就诊时平均疼痛强度评分更高,更有可能接受静脉或鼻内阿片类药物治疗,也更有可能住院。在一个考虑性别、高HCU疼痛史和从初始疼痛强度评分开始的随访时间之间的三向相互作用的模型中,调整每公斤体重的阿片类药物用量和羟基脲处方后,有高HCU疼痛史的青春期女性患者在ED急性疼痛治疗期间疼痛强度下降最慢。
性别和高HCU疼痛史与前往ED就诊的SCD青少年的急性疼痛轨迹有关。这些新发现应在未来的前瞻性研究中得到证实。